This opportunity is no longer accepting applications.
grant PAR-22-194

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

This grant opportunity invites applications to utilize the NHLBI-funded TOPMed program to create extensive genetic and multi-omics data for studying heart, lung, blood, and sleep disorders. The aim is to enhance understanding of these disorders' molecular mechanisms and address knowledge gaps not covered by current datasets. No funding is provided. The data will be stored in a public, controll…

This Funding Opportunity Announcement (FOA) invites applications to use the NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of heart, lung, blood, and sleep (…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute
Program: SBIR

Dates

Opportunity Released: June 1, 2022
Open for Submission: June 1, 2022
Submission Deadline: October 17, 2024
Application Window Closes: October 17, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.